Opus Genetics, Inc. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8da2cd48-2d11-4389-b4dd-03bdb7ea38f3/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $14.2M | 2025-01-01 – 2025-12-31 | evidence 0001140361-26-009247 |
| FY 2024 | $11.0M | 2024-01-01 – 2024-12-31 | evidence 0001140361-25-011410 |
| FY 2023 | $19.0M | 2023-01-01 – 2023-12-31 | evidence 0001140361-24-012399 |
| FY 2022 | $39.9M | 2022-01-01 – 2022-12-31 | evidence 0001140361-23-014868 |
| FY 2021 | $589.0k | 2021-01-01 – 2021-12-31 | evidence 0001140361-22-011015 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001140361-22-011015 |
| FY 2019 | $3.0M | 2019-01-01 – 2019-12-31 | evidence 0001140361-20-003785 |
| FY 2013 | $0 | 2001-03-19 – 2014-03-31 | evidence 0001140361-14-020971 |
| FY 2012 | $0 | 2012-01-01 – 2012-12-31 | evidence 0001140361-14-013828 |
| FY 2011 | $0 | 2001-03-19 – 2012-03-31 | evidence 0001140361-12-023967 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001140361-12-016054 |
| FY 2009 | $0 | 2009-01-01 – 2009-12-31 | evidence 0001140361-12-016054 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Opus Genetics, Inc. — all facts · Net Income · Operating Income